Skip to main content
TipRanks
Go Ultimate75% OFF

Immunovant (IMVT) Q2 2026 Earnings Report

964 Followers

IMVT Q2 2026 EPS Results

Actual EPS
-$0.73
Consensus EPS
-$0.71
Beat/Miss
Missed by -$0.02
One Year Ago EPS
-$0.74

IMVT Q2 2026 Revenue Results

Actual Revenue
$0
Expected Revenue
$0
Beat/Miss
Met expectations
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2026
Date
11/10/2025
Time
Before Open
Conference Call
Monday, November 10, 2025
IMVT Upcoming Earnings

Immunovant's next earnings date is estimated for February 16, 2027, based on past reporting schedules.

Q2 2026 Earnings Call Audio

IMVT Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

IMVT Earnings History

IMVT earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 16, 20272027 (Q3)-0.59--0.61――
Nov 09, 20262027 (Q2)-0.74-0.47-0.7335.62% (+0.26)
Aug 06, 20262027 (Q1)-0.63-0.75-0.71-5.63% (-0.04)
May 20, 20262026 (Q4)-0.59-0.73-0.64-14.06% (-0.09)
Feb 06, 20262026 (Q3)-0.71-0.61-0.7619.74% (+0.15)
Nov 10, 20252026 (Q2)-0.71-0.73-0.741.35% (+0.01)
Aug 11, 20252026 (Q1)-0.68-0.71-0.6-18.33% (-0.11)
May 29, 20252025 (Q4)-0.71-0.64-0.52-23.08% (-0.12)
Feb 06, 20252025 (Q3)-0.75-0.76-0.29-162.98% (-0.47)
Nov 07, 20242025 (Q2)-0.60-0.74-0.45-64.44% (-0.29)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed